Getting Health Care Right: A Conversation with Sarah AhmadJanuary 3rd, 2019
Highmark Health senior vice president of innovation and transformation strategy Sarah Ahmad leads a team that is all about getting health care right.
New Device Shows Encouraging Signs In Helping Reduce Panic AttacksSeptember 24th, 2018
Panic attacks can be debilitating. Medicine often helps, but now there’s a new treatment that’s offering a better solution.
Digital Health Trends Show a Promising FutureSeptember 14th, 2018
This year’s Accenture Digital Health Technology Vision touches on trends that aligned with Highmark Health’s mission to deliver value-based care. As an integrated delivery and financing system,we have an outstanding opportunity to take advantage of technology trends and test them out to see if they can deliver value to our patients and partners. We test cutting-edge healthcare solutions through the Highmark Health VITAL Innovation Program through which we partner with innovators to test, learn and understand the efficacy of technologies and think about how we can integrate them in our core business.
Biocept Bets on Oncology TestingSeptember 12th, 2018
Biocept has said that Highmark Health is testing its “liquid biopsy” platform designed to help oncologists improve the diagnosis and treatment of patients with non-small cell lung cancer. The goals are to improve health outcomes by using liquid biopsy to more rapidly assess a patient’s molecular status and select an appropriate therapy, while also reducing the overall cost of care. Highmark Health is the second-largest US integrated delivery and financing system. Their VITAL Innovation Program focuses on real-world testing of early-stage health innovations, producing evidence related to patient experience, and care and cost outcomes. More than 100 patients of Highmark Health-affiliated Allegheny Health Network Cancer Institute in Pittsburgh will participate.
How Highmark Health uses deep learning, 3D tech to cut unnecessary angiogramsAugust 20th, 2018
The health system deploys innovative FDA-approved technologies, enabling physicians to use AI algorithms to assess 3D models of the heart